Ashlee Dunston | Director, IR & Corporate Communications |
Sanjay Shukla | President & CEO |
Jill Broadfoot | CFO |
Joe Pantginis | H.C. Wainwright |
Hartaj Singh | Oppenheimer |
Edward Tenthoff | Piper Sandler |
Yale Jen | Laidlaw & Co |
Sean Kim | Jones Trading |
Kumaraguru Raja | ROTH Capital Partners |
Good afternoon, ladies and gentlemen and welcome to aTyr Pharma’s Third Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time.
As a reminder, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference call over to Ashlee Dunston, aTyr’s Director of Investor Relations and Corporate Communications.